http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-503036-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfedd8ba4800708cecfd357707f8f67
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
filingDate 1968-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fbc61e731b9cd688b94c54f17ed0350
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6d8956dbdf677de6db238417f573e5
publicationDate 1971-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-503036-A
titleOfInvention Process for the preparation of cytostatically active 5'-deoxy-5'-fluorine-substituted 2'-deoxyribonucleosides
abstract R = H, Ac P = purine or pyrimidine residue, e.g. 1-thyminyl 1-uracilyl, 1-(5-halouracilyl), 1-cytidyl, 9-adenyl or 9-guanyl The cpds. are cytostatically active, e.g. against Ehrlich ascites tumour cells in vitro. 2'-Desoxyribonucleosides contg. 5'-arylsulphonyl or 5'-mesyl radicals, & opt. acetylated, are treated with an alkali fluoride for 15 min. -5 hr. (pref. 1/2-2 hr) in a solvent such as acetamide, dimethylacetamide, glycol or MeOH, at 50-160 deg. (pref. 130-150 deg.) & the product purified by chromatography.
priorityDate 1967-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455858454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23708904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447836067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407515437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465144612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154340209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415802082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90674322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415801380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451057178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451268575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432424841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313

Total number of triples: 46.